Small and medium-scale farmers and agri-businesses in Southern and Eastern Africa, which are at the heart of inclusive food value chains, are not receiving fair prices for their produce.
Despite environmental education topics in curricula, not all children are aware of the elements that endanger the planet or actively involved in taking care of the environment.
Lars Laestadius, Swedish University of Agricultural Sciences; Chris Reij, World Resources Institute et Dennis Garrity, Center for International Forestry Research – World Agroforestry (CIFOR-ICRAF)
Africa’s Great Green Wall must immediately speed up to meet the needs of people along the edges of the Sahara Desert.
Big Food companies producing ulta-processed foods are using a range of key market and political practices to increase their reach, particularly in developing countries.
Michelle J. Groome, National Institute for Communicable Diseases et Janusz Paweska, National Institute for Communicable Diseases
Many African countries are experienced in managing outbreaks of viral haemorrhagic fevers and many of the lessons learnt from the Ebola can be applied to the Marburg outbreak.
The real burden of the disease is way underestimated. Not all the labs in the country are included in the tally an only a few can conduct COVID-19 tests.
Although there is no evidence yet that it affects COVID-19 vaccines, schistosomiasis, a neglected tropical disease, has been associated with lower vaccine immunity for several vaccines.
The African evidence community has built strong relationships across traditional boundaries. This has allowed researchers to mobilise quickly and effectively to improve policy outcomes.
Michelle J. Groome, National Institute for Communicable Diseases; Adrian Puren, National Institute for Communicable Diseases et Harry Moultrie, National Institute for Communicable Diseases
Communities with high vaccine coverage rates are likely to see lower case numbers, hospitalisations and deaths related to COVID-19 compared to those with poor vaccine coverage.
Countries must be encouraged to distribute essential healthcare provision - like diagnosis - to where people most need them and where they can be accessed more easily.
Thanks to the collaborative efforts of governments, funding agencies, academia, biotech and pharmaceutical companies, large-scale manufacturing of mRNA drug products is becoming a reality.
Dr Kim Jonas, South African Medical Research Council
An increase in the adolescent pregnancy rate strongly suggests challenges with accessing sexual and reproductive healthcare services for this vulnerable age group.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
Professor and Programme Director, SA MRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand